Formaldehyde

Formaldehyde

SCHEMBL4447100

C=O.ONCc1ccccc1

nearest known ligand 0.85

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.85
THRB P10828 1/20 0.85
CA2 P00918 2/20 0.52
CA1 P00915 1/20 0.52
ALOX12 P18054 2/20 0.48
ADH1B P00325 1/20 0.48
ADH1C P00326 1/20 0.48
ADH1A P07327 1/20 0.48
ADH7 P40394 1/20 0.48
ALDH1A1 P00352 1/20 0.48
HPGD P15428 1/20 0.48
CA12 O43570 1/20 0.48
CA7 P43166 1/20 0.48
CA14 Q9ULX7 1/20 0.48
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
TDP1 Q9NUW8 1/20 0.48
HDAC8 Q9BY41 3/20 0.47
HDAC6 Q9UBN7 3/20 0.47
HDAC2 Q92769 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL208455 0.92
Ammonia Solution, Strong SCHEMBL4940619 0.90 IDO1 (0.94) IDO1THRBCA2CA1ALOX12
Bromide SCHEMBL23360794 0.90 IDO1 (0.94) IDO1THRBCA2CA1ALOX12
Hydrochloric Acid SCHEMBL359448 0.90 IDO1 (0.94) IDO1THRBCA2CA1ALOX12
Hydrochloric Acid SCHEMBL8359792 0.87 IDO1 (0.90) IDO1THRBCA2CA1ALOX12
Hydroxyamine SCHEMBL250901 0.87 IDO1 (0.90) IDO1THRBCA2CA1ALOX12
Hydrochloric Acid SCHEMBL27851954 0.87 IDO1 (0.90) IDO1THRBCA2CA1ALOX12
SCHEMBL28863273 0.85 IDO1 (0.85) IDO1THRBCA2CA1ALOX12
Succinic Acid SCHEMBL29992800 0.84 THRB (0.74) IDO1THRBMEN1KMT2AHDAC8
Propane SCHEMBL5804162 0.83 IDO1 (0.81) IDO1THRBCA2CA1ALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090012011-A1 Novel Compounds SMITHKLINE BEECHAM CORPORATION (US) 2009-01-08 US disclosed
EP-1981596-A2 NOVEL COMPOUNDS SmithKline Beecham Corporation (US) 2008-10-22 EP disclosed
WO-2007082262-A2 NOVEL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2007-07-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012011-A1 Novel Compounds TRPV4, TRPV1, TRPV3 IDO1 1289/4885THRB 1068/4885CA2 439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.